Valuation: Ibnsina Pharma

Market Cap 11.7B 240M 210M 193M 180M 341M 22.87B 346M 2.32B 901M 11.23B 901M 881M 38.93B P/E 2026 *
9.54x
P/E 2027 * 6.52x
Enterprise Value 17.52B 359M 314M 290M 269M 510M 34.24B 517M 3.47B 1.35B 16.81B 1.35B 1.32B 58.28B EV / Sales 2026 *
0.19x
EV / Sales 2027 * 0.17x
Free-Float
70.08%
Yield 2026 *
2.58%
Yield 2027 * 5%
1 day+0.09%
1 week+1.40%
Current month-0.51%
1 month-7.19%
3 months+14.27%
6 months+5.55%
Current year-0.94%
1 week 11.52
Extreme 11.52
11.78
1 month 11.2
Extreme 11.2
12.74
Current year 9.63
Extreme 9.63
13.72
1 year 9.33
Extreme 9.33
13.72
3 years 1.78
Extreme 1.78
13.72
5 years 1.1
Extreme 1.101
13.72
10 years 1.1
Extreme 1.101
13.72
Manager TitleAgeSince
Chief Executive Officer - 2000-12-17
Chief Executive Officer - 2000-12-17
Director of Finance/CFO - -
Director TitleAgeSince
Director/Board Member - 2000-12-17
Director/Board Member - 2000-12-17
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+0.09%+1.40%+20.69%+383.75% 240M
+1.81%+4.41%-15.77%-4.95% 5.97B
+0.60%+6.36%-19.65%-32.82% 3.58B
-1.84%+2.14%-36.77%-8.42% 3.37B
+0.21%+1.13%-27.65%-45.26% 3.25B
+0.88%+11.11%+2.56%-36.25% 2.88B
-1.48%+2.32%+98.47% - 2.62B
+2.45%+1.38%-16.36%-2.00% 2.52B
-0.18%-4.93%+0.34%+40.59% 1.72B
+0.04%+4.02%-27.68%-37.32% 1.61B
Average +0.26%+3.86%-2.18%+28.59% 2.78B
Weighted average by Cap. +0.44%+4.21%-6.96%-13.14%

Financials

2026 *2027 *
Net sales 89.87B 1.84B 1.61B 1.49B 1.38B 2.62B 176B 2.65B 17.78B 6.92B 86.22B 6.92B 6.76B 299B 101B 2.07B 1.82B 1.67B 1.55B 2.95B 198B 2.99B 20.02B 7.79B 97.08B 7.79B 7.62B 337B
Net income 1.33B 27.18M 23.81M 21.93M 20.35M 38.65M 2.59B 39.18M 262M 102M 1.27B 102M 99.85M 4.41B 1.92B 39.44M 34.54M 31.81M 29.53M 56.08M 3.76B 56.83M 381M 148M 1.85B 148M 145M 6.4B
Net Debt 5.82B 119M 104M 96.15M 89.25M 169M 11.37B 172M 1.15B 448M 5.58B 448M 438M 19.35B 5.77B 118M 104M 95.41M 88.56M 168M 11.28B 170M 1.14B 444M 5.54B 444M 434M 19.2B
Logo Ibnsina Pharma
Ibnsina Pharma S.A.E. is Egypt's number two in the wholesale distribution of pharmaceutical products. The group offers medicines and cosmetics to more than 35,000 private and public sector customers (distribution chains, pharmacies, wholesalers and health establishments) through 55 sites located in Egypt.
Employees
5,500
Date Price Change Volume
26-07-06 EGP 11.61 +0.09% 3,326,163
26-07-05 EGP 11.60 0.00% 4,389,656
26-07-01 EGP 11.60 -0.60% 1,798,643
26-06-30 EGP 11.67 +1.92% 3,219,865
26-06-29 EGP 11.45 +1.33% 2,639,283
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
11.61EGP
Average target price
17.26EGP
Spread / Average Target
+48.64%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ISPH Stock